Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,000
Closed -$221K 4523
2021
Q3
$221K Sell
3,000
-9,000
-75% -$675K ﹤0.01% 3896
2021
Q2
$801K Buy
12,000
+7,800
+186% +$521K ﹤0.01% 2678
2021
Q1
$312K Buy
4,200
+200
+5% +$15.2K ﹤0.01% 3296
2020
Q4
$291K Buy
+4,000
New +$282K ﹤0.01% 2887
2018
Q4
Sell
-8,000
Closed -$328K 3209
2018
Q3
$328K Buy
+8,000
New +$323K ﹤0.01% 2713
2018
Q2
Sell
-50,800
Closed -$1.9M 3447
2018
Q1
$1.9M Buy
+50,800
New +$2.05M 0.01% 1562

Other funds holding HOLX

John Overdeck's HOLX Position: Q2 2026 in Review

John Overdeck sold out of Hologic (HOLX) in Q2 2026, closing a stake of 328,504 shares — an estimated $24.8M sold.

John Overdeck first reported a position in HOLX in Q3 2013 and held it in 46 quarters. The position peaked at $60.2M in Q4 2015. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • John Overdeck reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • John Overdeck sold 328,504 Hologic shares in Q2 2026, an estimated $24.8M.
  • John Overdeck first reported a position in Hologic in Q3 2013 and held it in 46 quarters.
  • John Overdeck's Hologic position peaked at $60.2M in Q4 2015.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.